Background: Multiple sclerosis (MS) is a multifocal inflammatory central nervous system
disorder. There are now many highly effective disease-modifying therapies (DMTs) available …

CE INFORMATION ACTIVITY AVAILABLE ONLINE: To access the article and evaluation
online, go to https://www. highmarksce. com/mscare. TARGET AUDIENCE: The target …

Multiple sclerosis (MS) is a neurodegenerative disease of the central nervous system. An
increase in MS incidence over time is reported in several regions of the world. We aimed to …

Background The Greater Hobart region (42.5° S) of Tasmania has consistently had the
highest recorded prevalence and incidence rates of multiple sclerosis (MS) in Australia. We …

Background: The MS disease-modifying therapies (DMTs) prescribing landscape in
Australia have changed over time. Objectives: This study evaluated the utilisation and cost …

Introduction Multiple sclerosis (MS) is an inflammatory disease in which the myelin sheaths
of the nerve cells in the brain and spinal cord, which are responsible for communication, are …

Abstract Background Economic costs of Multiple Sclerosis (MS) in Australia were last
estimated in 2010 and are likely to have changed over time, especially given this new era of …

BACKGROUND AND PURPOSE: Gadolinium enhanced MRI is routinely used for follow-up
of patients with multiple sclerosis. Our aim was to evaluate whether enhancing multiple …

Background Health-related quality of life (HRQoL) has not been assessed in Australians
with multiple sclerosis (MS) using a preferentially sensitive multi-attribute utility instrument …

Background Multiple sclerosis imposes a heavy burden on the person who suffers from it
and on the relatives, due to the caregiving load involved. The objective was to analyse …